IDXX Reports $1,141M Q1 Revenue, $3.47 EPS, Raises 2026 Guidance to $4.68B-$4.76B, +1% Midpoint, 8.6%-10.6% Growth
Idexx Laboratories Inc · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $566.79
-5.3% in 7d after detection
Post-detection moves
1h
—
1d
+2.9%
3d
-0.5%
7d
-5.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS